Results 51 to 60 of about 216,038 (323)

Metabolic, inflammatory and haemostatic effects of a low-dose continuous combined HRT in women with type 2 diabetes: potentially safer with respect to vascular risk? [PDF]

, 2003
BACKGROUND Conventional hormone replacement therapy (HRT) containing conjugated equine oestrogen (CEE) and medroxyprogesterone acetate (MPA) increases triglyceride, C- reactive protein (CRP) and coagulation Factor VII concentrations, potentially ...
Alan J. Jaap, Andersen, Anderson, Ann Rumley, Anne Kelly, Brussard, Cushman, Dichtl, Ferrara, Gordon D. Lowe, Gornstein, Herrington, Hokanson, Hulley, Ian A. Greer, John R. Petrie, Joyce McKenzie, Kanaya, Kenneth Paterson, Knopp, Koh, Kroon, Kroon, Lokkegaard, Lowe, Lowe, Lowe, Lynne Crawford, Manning, Meade, Naveed Sattar, Perera, Petitti, Pradhan, Rapp, Ridker, Ridker, Rossouw, Sattar, Sattar, Stephen Gallacher, Stork, Van Baal, Van Baal, Vehkavaara, Woodward, Zanger   +46 more
core   +1 more source

Depressive Syndromes in Men with Hypogonadism in the TRAVERSE Trial: Response to Testosterone Replacement Therapy.

Journal of Clinical Endocrinology and Metabolism
CONTEXT The effect of testosterone on depressive symptoms in men with hypogonadism remains incompletely understood. OBJECTIVE We assessed the effects of testosterone replacement therapy (TRT) in improving depressive symptoms in hypogonadal men with and
Shalender Bhasin, Stuart Seidman, T. Travison, K. Pencina, A. M. Lincoff, Steven E. Nissen, Michael G Miller, Panagiotis Flevaris, Xue Li, Kathleen Wannemuehler, H. G. Pope   +10 more
semanticscholar   +1 more source

Age-Related Male Hypogonadism and Cognitive Impairment in the Elderly: Focus on the Effects of Testosterone Replacement Therapy on Cognition

Geriatrics, 2020
Background. Epidemiological data report that male hypogonadism may play a role in cognitive impairment in elderly. However, the effect of testosterone replacement therapy (TRT) on cognitive abilities in this cluster of patients has not been well ...
G. Lisco, V. Giagulli, A. De Tullio, G. De Pergola, E. Guastamacchia, V. Triggiani   +5 more
semanticscholar   +1 more source

Testosterone replacement therapy and voiding dysfunction [PDF]

Translational Andrology and Urology, 2016
Testosterone replacement therapy (TRT) represents an increasing popular treatment option for men with late-onset hypogonadism (LOH). Because of unsubstantiated beliefs of testosterone's effect on the prostate, the FDA has recently placed a warning on testosterone products, stating that TRT may worsen benign prostatic hyperplasia (BPH).
Baas, Wesley, Köhler, Tobias S.
openaire   +2 more sources

The unsolved case of “bone-impairing analgesics”. The endocrine effects of opioids on bone metabolism [PDF]

, 2015
The current literature describes the possible risks for bone fracture in chronic analgesics users. There are three main hypotheses that could explain the increased risk of fracture associated with central analgesics, such as opioids: 1) the increased ...
COLUZZI, FLAMINIA, MATTIA, Consalvo, Pergolizzi, Joseph, Raffa, Robert B   +3 more
core   +3 more sources

The Potential Effects of Hormonal Therapy and Stress on the Oral Health of the Transitioning Population [PDF]

, 2020
Problem: In terms of healthcare, the transgender population is underserved. Unfortunately, these individuals often experience stress related to seeking preventative care and fear discrimination.
Cantwell, Elena G, McClure, Devon
core   +1 more source

Pharmacology of testosterone replacement therapy preparations [PDF]

Translational Andrology and Urology, 2016
The goal of testosterone replacement therapy (TRT) is to return serum testosterone levels to within physiologic range and improve symptoms in hypogonadal men. Some of the symptoms aimed to improve upon include decreased libido, erectile dysfunction, infertility, hot flashes, depressed mood, and loss of muscle mass or hair.
Shoskes, Jennifer J., Wilson, Meghan K., Spinner, Michael L.   +2 more
openaire   +2 more sources

Switch to restoration therapy in a testosterone treated central hypogonadism with erythrocytosis

Endocrinology, Diabetes & Metabolism Case Reports, 2017
We describe a case of severe erythrocytosis caused by testosterone replacement therapy in a 66-year-old man affected with hypogonadotropic hypogonadism (HH) determining osteoporosis, resolved by switching to restoration therapy with clomiphene citrate ...
B Cangiano, C Cacciatore, L Persani, M Bonomi   +3 more
doaj   +1 more source

The complex relation between obstructive sleep apnoea syndrome, hypogonadism and testosterone replacement therapy

Frontiers in Reproductive Health, 2023
Obstructive sleep apnoea syndrome (OSAS) is an under-recognized medical disease. The main risk factors for OSAS are male sex, older age, obesity, and metabolic syndrome, that are also associated with male hypogonadism (MH).
Andrea Graziani, Giuseppe Grande, Alberto Ferlin   +2 more
doaj   +1 more source

Risks of testosterone replacement therapy in men

Indian Journal of Urology, 2014
Testosterone replacement therapy (TRT) is a widely used treatment for men with symptomatic hypogonadism. The benefits seen with TRT, such as increased libido and energy level, beneficial effects on bone density, strength and muscle as well as ...
E Charles Osterberg, Aaron M Bernie, Ranjith Ramasamy   +2 more
doaj   +1 more source